查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1586114

心臟麻痹治療市場：依治療方法、通路分類 - 全球預測 2025-2030

Cardiac Arrest Treatment Market by Treatment (Drug, Medical Devices), Distribution Channel (Hospitals, Independent Pharmacies) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年心臟麻痹治療市場價值為217.7億美元，預計到2024年將達237.3億美元，複合年成長率為9.08%，到2030年將達到400.3億美元。

心臟麻痹治療包括緊急干預和長期醫療護理，以在心臟突然停止跳動後恢復正常心律和功能。這包括使用自動體外心臟心臟去顫器(AED)、心肺復甦術、高級心臟生命支持 (ACLS) 和低溫治療。心臟麻痹生命的性質及其在全球範圍內的高發病率強調了對有效心臟麻痹治療的需求。應用範圍從緊急醫療服務到醫院，主要最終用途是醫院、門診手術中心和急救人員。心臟麻痹治療市場主要是由心血管疾病盛行率上升、心臟健康意識提高、醫療技術進步以及獲得緊急醫療服務的機會的改善所推動的。在發展中地區，由於醫療基礎設施的改善和政府措施的增加，潛在的商機正在擴大。技術創新，例如開發具有增強連接性和方便用戶使用介面的攜帶式AED，代表著利潤豐厚的市場成長機會。然而，挑戰依然存在，包括先進醫療設備的成本高昂、偏遠地區獲得即時治療的機會有限以及醫療基礎設施的地區差異。另一個重要領域是需要對急救人員和旁觀者進行繼續教育，以改善治療結果。用於預測心臟事件的人工智慧主導解決方案的創新以及將物聯網整合到醫療設備中進行即時監測可能會指明一條成長之路。該市場競爭激烈且發展迅速，其特點是多家主要企業在研發方面投入大量資金。透過收購和聯盟進行的整合也在塑造市場格局。有效的客戶拓展和遵守監管標準是抓住這一重要領域新機會的推薦策略。

主要市場統計
基準年[2023] 217.7億美元
預測年份 [2024] 237.3億美元
預測年份 [2030] 400.3億美元
複合年成長率（%） 9.08%

市場動態：快速發展的心臟麻痹治療市場的關鍵市場洞察

供需的動態交互作用正在改變心臟麻痹治療市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 全球心臟病盛行率不斷上升
    • 政府針對心血管健康的舉措
    • 對治療心臟麻痹的醫療設備進步的認知
  • 市場限制因素
    • 與心臟麻痹相關的昂貴治療費用
  • 市場機會
    • 微創手術的出現
    • 心臟麻痹的治療和治療進展
  • 市場挑戰
    • 缺乏先進的醫療基礎設施和熟練的專業人員

波特的五力：駕馭心臟麻痹治療市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解心臟麻痹治療市場的外部影響

外部宏觀環境因素在塑造心臟麻痹治療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解心臟麻痹治療市場的競爭狀況

對心臟麻痹治療市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV 定位矩陣心臟麻痹治療市場供應商的績效評估

FPNV定位矩陣是評估心臟麻痹治療市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了心臟麻痹治療市場的成功之路

對於希望加強在全球市場的影響力的公司來說，心臟麻痹治療市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地心臟病的發生率正在增加
      • 政府針對心血管健康的舉措
      • 對心臟麻痹治療醫療設備進步的認知
    • 抑制因素
      • 與心臟麻痹相關的昂貴治療
    • 機會
      • 微創手術的出現
      • 心臟麻痹的治療和治療進展
    • 任務
      • 缺乏先進的醫療基礎設施和熟練的專業人員
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依治療分類的心臟麻痹治療市場

  • 藥品
    • 抗心律不整藥物
    • 抗膽鹼能藥物
    • BETA受體阻斷劑
    • 皮質類固醇
    • 纖溶藥物
    • 血管收縮劑
  • 醫療設備
    • 心臟再同步治療
    • 心臟去顫器

第7章心臟麻痹治療市場：按分銷管道

  • 醫院
  • 獨立藥房

第8章北美和南美心臟麻痹治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太心臟麻痹治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的心臟麻痹治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Amgen Inc.
  • Bayer AG
  • BIOTRONIK SE & CO., KG
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Company
  • Fukuda Denshi Co., Ltd
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips NV
  • LivaNova PLC
  • Medtronic PLC
  • Nihon Kohden Corporation
  • Novartis International AG
  • Pfizer Inc.
  • Stryker Corporation
  • ZOLL Medical Corporation
Product Code: MRR-433AB1DC2886

The Cardiac Arrest Treatment Market was valued at USD 21.77 billion in 2023, expected to reach USD 23.73 billion in 2024, and is projected to grow at a CAGR of 9.08%, to USD 40.03 billion by 2030.

Cardiac arrest treatment encompasses emergency interventions and long-term medical care designed to restore normal heart rhythm and function following a sudden stoppage of the heart. This includes the use of automated external defibrillators (AEDs), CPR, advanced cardiac life support (ACLS), and therapeutic hypothermia. The necessity for efficient cardiac arrest treatment is underscored by the life-threatening nature of cardiac arrest and its high incidence globally. Applications range from emergency medical services to hospital settings, with significant end-use in hospitals, ambulatory surgical centers, and among first responders. The market for cardiac arrest treatment is primarily driven by rising incidences of cardiovascular diseases, growing awareness about cardiac health, advancements in medical technology, and increased accessibility to emergency medical services. Potential opportunities are proliferating in developing regions due to improving healthcare infrastructure and increasing governmental initiatives for public health education. Technological innovation, such as the development of portable AEDs with enhanced connectivity and user-friendly interfaces, presents a lucrative opportunity for market growth. However, challenges persist, such as the high cost of advanced medical devices, limited access to immediate care in remote areas, and variability in healthcare infrastructure across regions. The need for continuous education among emergency responders and bystanders to improve treatment outcomes is another critical area. Innovation in AI-driven solutions for predicting cardiac events and integrating IoT in medical devices for real-time monitoring could present paths for growth. The market is competitive and rapidly evolving, characterized by the presence of several key players investing heavily in R&D. Consolidation through acquisitions and partnerships also shapes the market landscape. Effective customer outreach and compliance with regulatory standards are recommended strategies for capturing emerging opportunities in this vital sector.

KEY MARKET STATISTICS
Base Year [2023] USD 21.77 billion
Estimated Year [2024] USD 23.73 billion
Forecast Year [2030] USD 40.03 billion
CAGR (%) 9.08%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiac Arrest Treatment Market

The Cardiac Arrest Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of cardiac disorders worldwide
    • Government initiatives for cardiovascular health and wellness
    • Awareness related to advancements in medical devices for the treatment of cardiac arrest
  • Market Restraints
    • Expensive treatments associated with cardiac arrest
  • Market Opportunities
    • Emergence of minimally invasive procedures
    • Advancements in cardiac arrest treatments and procedures
  • Market Challenges
    • Lack of advanced healthcare infrastructure and skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Cardiac Arrest Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiac Arrest Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiac Arrest Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiac Arrest Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiac Arrest Treatment Market

A detailed market share analysis in the Cardiac Arrest Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiac Arrest Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiac Arrest Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiac Arrest Treatment Market

A strategic analysis of the Cardiac Arrest Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Arrest Treatment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amgen Inc., Bayer AG, BIOTRONIK SE & CO., KG, Boston Scientific Corporation, Bristol-Myers Squibb Company, Fukuda Denshi Co., Ltd, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., LivaNova PLC, Medtronic PLC, Nihon Kohden Corporation, Novartis International AG, Pfizer Inc., Stryker Corporation, and ZOLL Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiac Arrest Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment, market is studied across Drug and Medical Devices. The Drug is further studied across Anti-Arrhythmic Drugs, Anticholinergic Drugs, Beta Blockers, Corticosteroids, Fibrinolytic Drugs, and Vasopressors. The Medical Devices is further studied across Cardiac Resynchronization Therapy and Defibrillators.
  • Based on Distribution Channel, market is studied across Hospitals and Independent Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of cardiac disorders worldwide
      • 5.1.1.2. Government initiatives for cardiovascular health and wellness
      • 5.1.1.3. Awareness related to advancements in medical devices for the treatment of cardiac arrest
    • 5.1.2. Restraints
      • 5.1.2.1. Expensive treatments associated with cardiac arrest
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of minimally invasive procedures
      • 5.1.3.2. Advancements in cardiac arrest treatments and procedures
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of advanced healthcare infrastructure and skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiac Arrest Treatment Market, by Treatment

  • 6.1. Introduction
  • 6.2. Drug
    • 6.2.1. Anti-Arrhythmic Drugs
    • 6.2.2. Anticholinergic Drugs
    • 6.2.3. Beta Blockers
    • 6.2.4. Corticosteroids
    • 6.2.5. Fibrinolytic Drugs
    • 6.2.6. Vasopressors
  • 6.3. Medical Devices
    • 6.3.1. Cardiac Resynchronization Therapy
    • 6.3.2. Defibrillators

7. Cardiac Arrest Treatment Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Independent Pharmacies

8. Americas Cardiac Arrest Treatment Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Cardiac Arrest Treatment Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Cardiac Arrest Treatment Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Amgen Inc.
  • 3. Bayer AG
  • 4. BIOTRONIK SE & CO., KG
  • 5. Boston Scientific Corporation
  • 6. Bristol-Myers Squibb Company
  • 7. Fukuda Denshi Co., Ltd
  • 8. Johnson & Johnson Services, Inc.
  • 9. Koninklijke Philips N.V.
  • 10. LivaNova PLC
  • 11. Medtronic PLC
  • 12. Nihon Kohden Corporation
  • 13. Novartis International AG
  • 14. Pfizer Inc.
  • 15. Stryker Corporation
  • 16. ZOLL Medical Corporation

LIST OF FIGURES

  • FIGURE 1. CARDIAC ARREST TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIAC ARREST TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CARDIAC ARREST TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CARDIAC ARREST TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIAC ARREST TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIAC ARREST TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY ANTI-ARRHYTHMIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY ANTICHOLINERGIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY BETA BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY FIBRINOLYTIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY VASOPRESSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 191. CARDIAC ARREST TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. CARDIAC ARREST TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023